| Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma P Nghiem, S Bhatia, EJ Lipson, WH Sharfman, RR Kudchadkar, AS Brohl, ... Journal for immunotherapy of cancer 9 (4), 2021 | 86 | 2021 |
| Immune checkpoint inhibitors to treat cutaneous malignancies DM Barrios, MH Do, GS Phillips, MA Postow, T Akaike, P Nghiem, ... Journal of the American Academy of Dermatology 83 (5), 1239-1253, 2020 | 79 | 2020 |
| High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma T Akaike, J Qazi, A Anderson, FS Behnia, MM Shinohara, G Akaike, ... British Journal of Dermatology 184 (2), 319-327, 2021 | 39 | 2021 |
| Imaging of Merkel cell carcinoma: what imaging experts should know G Akaike, T Akaike, SA Fadl, K Lachance, P Nghiem, F Behnia Radiographics 39 (7), 2069-2084, 2019 | 29 | 2019 |
| How we treat Merkel cell carcinoma: within and beyond current guidelines SY Park, C Doolittle-Amieva, Y Moshiri, T Akaike, U Parvathaneni, ... Future Oncology 17 (11), 1363-1377, 2021 | 28 | 2021 |
| Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer T Akaike, P Nghiem Journal of dermatological science 105 (1), 2-10, 2022 | 12 | 2022 |
| 590 Detecting Merkel cell carcinoma recurrence using a blood test: outcomes from 774 patients K Lachance, T Akaike, K Cahill, L Zawacki, N Singh, C Doolittle-Amieva, ... Journal of Investigative Dermatology 139 (5), S101, 2019 | 8 | 2019 |
| The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence. T Akaike, N So, DS Hippe, L Gunnell, C Doolittle-Amieva, K Lachance, ... Journal of Clinical Oncology 40 (16_suppl), 9566-9566, 2022 | 7 | 2022 |
| The evolving treatment landscape of Merkel cell carcinoma N Singh, EM McClure, T Akaike, SY Park, ET Huynh, PH Goff, P Nghiem Current Treatment Options in Oncology 24 (9), 1231-1258, 2023 | 3 | 2023 |
| Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review T Akaike, K Cahill, G Akaike, ET Huynh, DS Hippe, MM Shinohara, J Liao, ... Cancers 14 (23), 5914, 2022 | 2 | 2022 |
| Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy LM Tachiki, L Zawacki, DS Hippe, Y Moshiri, N Alexander, T Akaike, ... Journal of Investigative Dermatology 142 (10), 2840, 2022 | 1 | 2022 |
| 292 Is it safe to discontinue immunotherapy after a response in Merkel cell carcinoma? L Tachiki, L Zawacki, D Hippe, Y Moshiri, N Alexander, T Akaike, ... Journal of Investigative Dermatology 142 (8), S50, 2022 | 1 | 2022 |
| 675 Utility of circulating tumor DNA testing in Merkel cell carcinoma patients T Akaike, C Doolittle-Amieva, K Lachance, AS Fonseca, C Church, E Hall, ... Journal of Investigative Dermatology 141 (5), S117, 2021 | 1 | 2021 |
| 497 Efficacy of immunotherapy in Merkel cell carcinoma patients with chronic immunosuppression L Zawacki, K Lachance, T Akaike, P Nghiem Journal of Investigative Dermatology 140 (7), S67, 2020 | 1 | 2020 |
| 1545 Circulating tumor DNA reflects tumor burden and detects early recurrence in patients with Merkel cell carcinoma T Akaike, DS Hippe, N So, N Maloney, L Gunnell, E Hall, A Rodriguez, ... Journal of Investigative Dermatology 143 (5), S265, 2023 | | 2023 |
| 1575 Merkel cell carcinoma in solid organ transplant recipients: Baseline characteristics and response to immunotherapy N Singh, T Akaike, A Fu, K Cahill, L Gunnell, DS Hippe, E Lipson, N Vohra, ... Journal of Investigative Dermatology 143 (5), S270, 2023 | | 2023 |
| 562 Merkel polyomavirus antibody testing for detecting recurrent Merkel cell carcinoma: A prospective, real-world outcomes study L Gunnell, T Akaike, K Lachance, DS Hippe, K Cahill, C Doolittle-Amieva, ... Journal of Investigative Dermatology 143 (5), S96, 2023 | | 2023 |
| 434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an option E McClure, T Akaike, ET Huynh, N Harikrishnan, K Lachance, C Church, ... Journal of Investigative Dermatology 143 (5), S75, 2023 | | 2023 |
| 512 Single-fraction postoperative radiotherapy in early-stage merkel cell carcinoma (MCC): Effectiveness and reduced toxicity ET Huynh, PH Goff, K Lachance, N Harikrishnan, T Akaike, M Cook, ... Journal of Investigative Dermatology 143 (5), S88, 2023 | | 2023 |
| 447 Immunotherapy efficacy in Merkel cell carcinoma is affected by the presence and type of immunosuppression: Analysis of 183 patients E Gong, DS Hippe, X Fan, L Zawacki, AJ Remington, A Menon, ... Journal of Investigative Dermatology 143 (5), S77, 2023 | | 2023 |
Paul NghiemUniversity of Washington; Fred Hutchinson Cancer CenterVerified email at uw.edu
